Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

NCT01555892 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Disease
Non-Hodgkin's Lymphoma
Lymphoproliferative Disease
Lymphoma

Interventions

BIOLOGICAL: EBV-specific T cells: A
BIOLOGICAL: EBV-specific T cells: B

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]